| Citation:Reddy JK,Chaitanya V,Shah N,Guduru VP,Khan S,Kuttupalayam S.Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery.Int J Ophthalmol 2019;12(5):774-778,doi:10.18240/ijo.2019.05.11 |
|
| Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery |
| Received:July 13, 2018 Revised:February 25, 2019 |
| Email this Article Add to Favorites Print |
| DOI：10.18240/ijo.2019.05.11 |
| Key Words:intraocular pressure subconjunctival triamcinolone acetonide phacoemulsification loteprednol cells/flare less drop cataract surgery |
| Fund Project: |
| Author | Institution |
| Jagadeesh Kumar Reddy |
Department of Cornea, Sankara Eye Hospital, Coimbatore , Tamil Nadu, India |
| Vivek Chaitanya |
Department of Cornea, Sankara Eye Hospital, Coimbatore , Tamil Nadu, India |
| Neeraj Shah |
Department of Cornea, Sankara Eye Hospital, Coimbatore , Tamil Nadu, India |
| Venkata Prabhakar Guduru |
Department of Cornea, Sankara Eye Hospital, Coimbatore , Tamil Nadu, India |
| Shadab Khan |
Department of Cornea, Sankara Eye Hospital, Coimbatore , Tamil Nadu, India |
| Siddharthan Kuttupalayam |
Department of Cornea, Sankara Eye Hospital, Coimbatore , Tamil Nadu, India |
|
| Hits: 1244 |
| Download times: 234 |
| Abstract: |
| AIM: To do a randomized prospective interventional study for comparing the effects of a single subconjunctival triamcinolone acetonide (SCTA) injection to tapering topical loteprednol in patients undergoing phacoemulsification surgery under topical anesthesia.
METHODS: A total of 400 patients were randomized into 2 groups; Group A (200 patients) received 5 mg SCTA at the end of surgery and topical ketorolac tromethamine (0.5%) with ofloxacin (0.3%) combination for 3wk. Group B (200 patients) received tapering topical loteprednol etabonate (0.5%) along with ofloxacin (0.3%) and ketorolac tromethamine (0.5%) for 3wk. Outcomes evaluated were intraocular pressure (IOP), anterior chamber cells/flare and macular oedema postoperatively at 1, 6 and 12wk.
RESULTS: Baseline parameters were almost similar in both the groups. No statistical difference was seen between the preoperative and postoperative IOP values for Group A (P=0.82) and Group B (P=0.61) and postoperative IOP values in between both groups (P=0.14) at 1wk. Incidence of cells/flare postoperative was statistically not significant (P=0.82) in both groups at all follow up visits. Postoperative macular oedema was not observed at any follow up visit.
CONCLUSION: SCTA appears to be an effective alternative to prolong postoperative topical steroid use. |
| Supplementary Material |
| PDF Fulltext Download reader View/Add Comment |
|
|
|
|
